1.0EUR
1.44 BEUR
12.90 BEUR
1.46 B
About BOSTON SCIENTIFIC DL-,01
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Employees (FY)
48 K
Founded
1979
FIGI
BBG000F9XMB6
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BSX is 63.5 EUR — it has increased by 0.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BOSTON SCIENTIFIC DL-,01 stocks are traded under the ticker BSX.
BOSTON SCIENTIFIC DL-,01 is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
BSX stock is 0.79% volatile and has beta coefficient of 0.77. Check out the list of the most volatile stocks — is BOSTON SCIENTIFIC DL-,01 there?
BSX earnings for the last quarter are 0.47 EUR per share, whereas the estimation was 0.45 EUR resulting in a 4.76% surprise. The estimated earnings for the next quarter are 0.46 EUR per share. See more details about BOSTON SCIENTIFIC DL-,01 earnings.
BOSTON SCIENTIFIC DL-,01 revenue for the last quarter amounts to 3.34 B EUR despite the estimated figure of 3.29 B EUR. In the next quarter revenue is expected to reach 3.26 B EUR.
Yes, you can track BOSTON SCIENTIFIC DL-,01 financials in yearly and quarterly reports right on TradingView.
BSX stock has risen by 0.79% compared to the previous week, the month change is a 2.16% rise, over the last year BOSTON SCIENTIFIC DL-,01 has showed a 38.07% increase.
BSX net income for the last quarter is 456.63 M EUR, while the quarter before that showed 476.78 M EUR of net income which accounts for −4.23% change. Track more BOSTON SCIENTIFIC DL-,01 financial stats to get the full picture.
Today BOSTON SCIENTIFIC DL-,01 has the market capitalization of 94.74 B, it has increased by 2.21% over the last week.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOSTON SCIENTIFIC DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 48.00 K employees. See our rating of the largest employees — is BOSTON SCIENTIFIC DL-,01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOSTON SCIENTIFIC DL-,01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOSTON SCIENTIFIC DL-,01 stock shows the buy signal. See more of BOSTON SCIENTIFIC DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BOSTON SCIENTIFIC DL-,01 future price: according to them, BSX price has a max estimate of 76.11 EUR and a min estimate of 59.19 EUR. Read a more detailed BOSTON SCIENTIFIC DL-,01 forecast: see what analysts think of BOSTON SCIENTIFIC DL-,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOSTON SCIENTIFIC DL-,01 EBITDA is 3.06 B EUR, and current EBITDA margin is 23.71%. See more stats in BOSTON SCIENTIFIC DL-,01 financial statements.